GSTM1 and GSTT1 polymorphisms in healthy volunteers – a worldwide systematic review

References

• Benton ML, Abraham A, LaBella AL, Abbot P, Rokas A, Capra JA. 2021. The influence of evolutionary history on human health and disease. Nat Rev Genet. 22(5):269–283.
   PubMed Web of Science ®Google Scholar
• Borrell LN, Elhawary JR, Fuentes-Afflick E, Witonsky J, Bhakta N, Wu AHB, Bibbins-Domingo K, Rodríguez-Santana JR, Lenoir MA, Gavin JR, et al. 2021. Race and genetic ancestry in medicine — a time for reckoning with racism. N Engl J Med. 384(5):474–480.
   PubMed Web of Science ®Google Scholar
• Budai B, Prekopp P, Noszek L, Kovács ER, Szőnyi M, Erdélyi DJ, Bíró K, Géczi L. 2020. GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs. J Mol Med (Berl). 98(7):963–971.
   PubMed Web of Science ®Google Scholar
• Byeon JY, Kim YH, Lee CM, Kim SH, Chae WK, Jung EH, Choi CI, Jang CG, Lee SY, Bae JW, et al. 2018. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes. Arch Pharm Res. 41(9):921–930.
   PubMed Web of Science ®Google Scholar
• Campbell MC, Tishkoff SA. 2010. The evolution of human genetic and phenotypic variation in Africa. Curr Biol. 20(4):166–173.
   PubMed Web of Science ®Google Scholar
• Coates MM, Kamanda M, Kintu A, Arikpo I, Chauque A, Mengesha MM, Price AJ, Sifuna P, Wamukoya M, Sacoor CN, et al. 2019. A comparison of all-cause and cause-specific mortality by household socioeconomic status across seven INDEPTH network health and demographic surveillance systems in sub-Saharan Africa. Glob Health Action. 12(1):1–12.
   Web of Science ®Google Scholar
• De Oliveira AÁS, Souza MD, Lengert AVH, De Oliveira MT, Camargo R, Braga GÚL, Cólus IMDS, Barbosa F, Barcelos GRM. 2014. Genetic polymorphisms in glutathione GSH- related genes affect the plasmatic Hg/whole blood Hg partitioning and the distribution between inorganic and methylmercury levels in plasma collected from a fish-eating population. Biomed Res Int. 2014:1–8.
   Web of Science ®Google Scholar
• Degarege A, Fennie K, Degarege D, Chennupati S, Madhivanan P. 2019. Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: a systematic review and meta-analysis. PLoS One. 14(1):e0211205.
   PubMed Web of Science ®Google Scholar
• Dodgen TM, De J Labuschagne C, Van Schalkwyk A, Steffens FE, Gaedigk A, Cromarty AD, Alessandrini M, Pepper MS. 2016. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort. Pharmacogenomics J. 16(6):566–572.
   PubMed Web of Science ®Google Scholar
• El Hajj T, Gregorius S, Pulford J, Bates I. 2020. Strengthening capacity for natural sciences research: a qualitative assessment to identify good practices, capacity gaps and investment priorities in African research institutions. PLoS One. 15(1):e0228261.
   PubMed Web of Science ®Google Scholar
• Fuselli S, De Filippo C, Mona S, Sistonen J, Fariselli P, Destro-Bisol G, Barbujani G, Bertorelle G, Sajantila A. 2010. Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet Genomics. 20(8):485–499.
   PubMed Web of Science ®Google Scholar
• Gattas GJF, Soares-Vieira JA. 2000. Cytochrome P450-2E1 and glutathione S-transferase mu polymorphisms among Caucasians and mulattoes from Brazil. Occup Med (Lond). 50(7):508–511.
   PubMed Web of Science ®Google Scholar
• Gómez-Martín A, Martinez-Gonzalez LJ, Puche-Sanz I, Cozar JM, Lorente JA, Hernández AF, Alvarez-Cubero MJ. 2019. GSTM1 gene expression and copy number variation in prostate cancer patients – effect of chemical exposures and physical activity. Urol Oncol. 37(4):290.e9–e15.
   PubMed Web of Science ®Google Scholar
• Gurdasani D, Barroso I, Zeggini E, Sandhu MS. 2019. Genomics of disease risk in globally diverse populations. Nat Rev Genet. 20(9):520–535.
   PubMed Web of Science ®Google Scholar
• He Y, Hoskins JM, McLeod HL. 2011. Copy number variants in pharmacogenetic genes. Trends Mol Med. 17(5):244–251.
   PubMed Web of Science ®Google Scholar
• Hekim N, Gure MA, Metin Mahmutoglu A, Gunes S, Asci R, Henkel R. 2020. SNP's in xenobiotic metabolism and male infertility. Xenobiotica. 50(3):363–370.
   PubMed Web of Science ®Google Scholar
• Henn BM, Botigué LR, Gravel S, Wang W, Brisbin A, Byrnes JK, Fadhlaoui-Zid K, Zalloua PA, Moreno-Estrada A, Bertranpetit J, et al. 2012. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet. 8(1):e1002397.
   PubMed Web of Science ®Google Scholar
• Hu CY, Lu DL, Wu T, Cheng SL, Wu TT, Wang S, Zhang T, Pang MG. 2019. Glutathione-S-transferases M1/T1 gene polymorphisms and male infertility risk in Chinese populations: a meta-analysis. Med (United States). 98(6):1–9.
   Google Scholar
• Huang YS. 2010. Tailored drug therapy for mitigating drug-induced liver injury: is this the era of genetic screening? Per Med. 7(1):5–8.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. 2005. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 5(1):6–13.
   PubMed Web of Science ®Google Scholar
• Jakovljevic TS, Jacimovic J, Nikolic N, Milasin J. 2020. Lack of association between glutathione S-transferase M1 and T1 gene polymorphisms and susceptibility to preeclampsia: an updated systematic review and meta-analysis. Am J Reprod Immunol. 84(6):1–11.
   Web of Science ®Google Scholar
• Li J, Lao X, Zhang C, Tian L, Lu D, Xu S. 2014. Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for Pharmacogenomics. BMC Genet. 15:52–15.
   PubMed Web of Science ®Google Scholar
• Lien S, Larsson AK, Mannervik B. 2002. The polymorphic human glutathione transferase T1-1, the most efficient glutathione transferase in the denitrosation and inactivation of the anticancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochem Pharmacol. 63(2):191–197.
   PubMed Web of Science ®Google Scholar
• Limdi NA, International Warfarin Pharmacogenetics Consortium, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MTM, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, et al. 2010. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood. 115(18):3827–3834.
   PubMed Web of Science ®Google Scholar
• LLerena A, Naranjo MEG, Rodrigues-Soares F, Penas-LLedó EM, Fariñas H, Tarazona-Santos E. 2014. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opin Drug Metab Toxicol. 10(11):1569–1583.
   PubMed Web of Science ®Google Scholar
• Lucena MI, Spanish Group for the Study of Drug-Induced Liver Disease, Andrade RJ, Martínez C, Ulzurrun E, García-Martín E, Borraz Y, Fernández MC, Romero-Gomez M, Castiella A, Planas R, et al. 2008. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology. 48(2):588–596.
   PubMed Web of Science ®Google Scholar
• Mensah GA, Jaquish C, Srinivas P, Papanicolaou GJ, Wei GS, Redmond N, Roberts MC, Nelson C, Aviles-Santa L, Puggal M, et al. 2019. Emerging concepts in precision medicine and cardiovascular diseases in racial and ethnic minority populations. Circ Res. 125(1):7–13.
   PubMed Web of Science ®Google Scholar
• Mlakar V, Curtis PHD, Armengol M, Ythier V, Dupanloup I, Hassine KB, Lesne L, Murr R, Mlakar SJ, Nava T, et al. 2021. The analysis of GSTA1 promoter genetic and functional diversity of human populations. Sci Rep. 11(1). https://www.nature.com/articles/s41598-021-83996-2
   PubMed Web of Science ®Google Scholar
• Obayashi K, Nakamura K, Kawana J, Ogata H, Hanada K, Kurabayashi M, Hasegawa A, Yamamoto K, Horiuchi R. 2006. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Clin Pharmacol Ther. 80(2):169–178.
   PubMed Web of Science ®Google Scholar
• Patterson N, Moorjani P, Luo Y, Mallick S, Rohland N, Zhan Y, Genschoreck T, Webster T, Reich D. 2012. Ancient admixture in human history. Genetics. 192(3):1065–1093.
   PubMed Web of Science ®Google Scholar
• Pereira V, EUROFORGEN-NoE Consortium, Freire-Aradas A, Ballard D, Børsting C, Diez V, Pruszkowska-Przybylska P, Ribeiro J, Achakzai NM, Aliferi A, Bulbul O, et al. 2019. Development and validation of the EUROFORGEN NAME (North African and Middle Eastern) ancestry panel. Forensic Sci Int Genet. 42:260–267.
   PubMed Web of Science ®Google Scholar
• Ramos E, Doumatey A, Elkahloun AG, Shriner D, Huang H, Chen G, Zhou J, McLeod H, Adeyemo A, Rotimi CN. 2014. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics J. 14(3):217–222.
   PubMed Web of Science ®Google Scholar
• Rodrigues-Soares F, Kehdy FSG, Sampaio-Coelho J, Andrade PXC, Céspedes-Garro C, Zolini C, Aquino MM, Barreto ML, Horta BL, Lima-Costa MF, et al. 2018. Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative. Pharmacogenomics J. 18(6):749–759.
   PubMed Web of Science ®Google Scholar
• Rostami G, Assad D, Ghadyani F, Hamid M, Karami A, Jalaeikhoo H, Kalahroodi RA. 2019. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response. Mol Genet Genomic Med. 7(7):1–10.
   Web of Science ®Google Scholar
• Saitou M, Satta Y, Gokcumen O. 2018. Complex haplotypes of GSTM1 gene deletions harbor signatures of a selective sweep in East Asian populations. G3 (Bethesda). 8(9):2953–2966.
   PubMedGoogle Scholar
• Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, Rodríguez-Antona C. 2018. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med. 20(6):622–629.
   PubMed Web of Science ®Google Scholar
• Sirugo G, Williams SM, Tishkoff SA. 2019. The missing diversity in human genetic studies. Cell. 177(1):26–31.
   PubMed Web of Science ®Google Scholar
• Song L, Yang C, He XF. 2020. Individual and combined effects of GSTM1 and GSTT1 polymorphisms on colorectal cancer risk: an updated meta-analysis. Biosci Rep. 40(8):1–25.
   Web of Science ®Google Scholar
• Wang J. 2018. Effects of sampling close relatives on some elementary population genetics analyses. Mol Ecol Resour. 18(1):41–54.
   PubMed Web of Science ®Google Scholar
• Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, Highland HM, Patel YM, Sorokin EP, Avery CL, et al. 2019. Genetic analyses of diverse populations improves discovery for complex traits. Nature. 570(7762):514–518.
   PubMed Web of Science ®Google Scholar
• Yu P, Kusuma JD, Suarez MAR, Shiao SYPK. 2018. Correction: Lung cancer susceptibility from GSTM1 deletion and air pollution with smoking status: a meta-prediction of worldwide populations. Oncotarget. 9(90):36251.
   PubMedGoogle Scholar
• Zhang X, Yang J, Liu X, Zhao G, Li X, Xun G. 2020. Glutathione S-transferase gene polymorphisms (GSTT1 and GSTM1) and risk of schizophrenia: A case-control study in Chinese Han population. Medicine (Baltimore). 99(36):e21918.
   PubMed Web of Science ®Google Scholar
• Zhao T, Ma F, Yin F. 2018. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in childhood acute lymphoblastic leukemia risk: an updated meta-analysis. Minerva Pediatr. 70(2):185–196.
   PubMed Web of Science ®Google Scholar
• Zhou T, Li HY, Xie WJ, Zhong Z, Zhong H, Lin ZJ. 2018. Association of glutathione S-transferase gene polymorphism with bladder cancer susceptibility. BMC Cancer. 18(1):1–16.
   PubMed Web of Science ®Google Scholar